Allergan (AGN) Declares $0.72 Quarterly Dividend; 1.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Allergan (AGN) Tops Q3 EPS by 18c, Revenues Beat; Lifts FY18 Revenue Guidance Outlook
October 30, 2018 6:33 AM EDTAllergan (NYSE: AGN) reported Q3 EPS of $4.15, $0.18 better than the analyst estimate of $3.97. Revenue for the quarter came in at $4.03 billion versus the consensus estimate of $3.82 billion.
"Allergan's performance in the third quarter of 2018 highlights the momentum in our business and our focus on execution. We continued to deliver solid results in the third quarter, driven by double-digit growth from many of our key... More
Allergen (AGN) PT Raised to $220 at RBC Capital
October 24, 2018 6:49 AM EDTRBC Capital analyst Randall Stanicky raised the price target on Allergen (NYSE: AGN) to $220.00 (from $213.00) while maintaining a Outperform rating.
Stanicky looks at three main themes relative to the current set-up:
(1) We expect a formal shift from strategic focus to pipeline; several important 2019... More
